Tilray Beverages Climbs to #4! Cheers to Ranking Among the Top Craft Brewers in the U.S.!

“Access to our collaborators’ expertise and support will help us further expand on the utility of the MSC test and ensure that we are able to expedite integration of this novel technology as a ...

Vaxart believes that its proprietary pill vaccine delivery platform is suitable to deliver recombinant vaccines, positioning the company to develop oral versions of currently marketed vaccines and to ...

Addgene is thrilled to have the expertise of this group of leaders in life sciences and technology as part of our management team and Board of Directors – a testament to the value of our vision for a ...

(Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that ...

The Tigris Trial is a confirmatory study of PMX in addition to standard care vs standard care alone and is designed as a 2:1 randomized trial of 150 patients using Bayesian statistics. Endotoxic ...

The Company granted stock options to purchase up to an aggregate of 65,000 shares of EyePoint common stock to four new employees. The stock options were granted on April 15, 2025. The grants were ...

Median overall survival of 17.3 months in Bria-IMT™ treated patients with hormone receptor positive (HR+) metastatic breast cancer markedly exceeds historical data of 14.4 months in TRODELVY® ...

Securing the $5.1 million repayment waiver is a significant milestone in this effort. This waiver strengthens our balance sheet by eliminating this outstanding debt obligation. We are grateful for the ...

OXFORD, United Kingdom, April 16, 2025 (GLOBE NEWSWIRE) -- Dr. Daniel Chen, at the University of Oxford and Chief Scientist at biotech startup Oxperial BioHealth, revealed their major breakthrough in ...

As previously announced, all required filings have been filed by the Company. Following the filing of required filings, the OSC has revoked the MCTO. Copies of the required filings are available on ...

Boca Raton, Florida, US, April 16, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB), a clinical-stage biotechnology company targeting inflammation and immunology through the innate immune ...